Supeinfection of mink cells nonproductively transformed by
AbLV-with either a wild mouse amphotropic type C virus isolate, 4070-A, or with the endogenous cat virus, RD114-led to production of pseudotype virus containing high concentrations of the AbLV-coded precursor polyprotein. Mammalian type C RNA tumor viruses exist as either infectious leukemia viruses or as replication-defective transforming viruses. The infectious viruses replicate in, but do not morphologically transform, fibroblast embryo cultures (1) and exist in a naturally integrated state in the cellular genome of a broad range of mammalian species (2, 3) . In contrast, transforming viruses frequently cause morphologic alteration of fibroblasts in cell culture (1) , require helper viruses for completion of their replication cycle (1, 4) , and cause fibrosarcoma (5, 6) , lymphoma (7), or erythroleukemia (8) upon in vito inoculation into appropriate hosts. Such transforming viruses appear to have arisen as a result of genetic recombination between type C leukemia viruses and host cell genetic sequences coding for malignant transformation (9, 10) .
The type C viral genome contains discrete regions that code for the major nonglycosylated virus structural proteins (gag), the reverse transcriptase (RNA-dependent DNA polymerase) (pol), and the envelope glycoprotein (env) (11) . On the basis of indirect evidence (12, 13) and by analogy to avian type C viruses (14) , the order of these genes within the mammalian type C viral genome appears to be 5'-gag-pol-env-3'. The primary translational product of the gag gene has been shown to be a 65,000-molecular weight (Mr) precursor that, upon posttranslational processing, gives rise to structural proteins of 30,000-(p30), 15 ,000-(pl5), 12 ,000-(p12), and 10,000-(plO) Mr (15, 16) . The internal arrangement of the gag gene has been
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established as 5'-pl5-pl2-p0pl-3' for both murine (16, 17) and feline (18) type C virus isolates. Replication-defective sarcoma viruses contain an additional transforming gene designated src, apparently derived from the host from which the virus was originally isolated (10, 19) . Cells nonproductively transformed by each of several different replication-defective transforming viruses have been shown to express differing numbers of helper virus structural proteins (16, 18, 20) . With one possible exception (21) , such expression appears to be.limited to the gag gene-coded proteins and occurs in a progressive manner from the 5' to 3' terminus of the gag gene (16, 18, 20, 22) .
Mammalian cells nonproductively transformed by feline sarcoma virus (FeSV) express an 130,000-Mr polyprotein that contains antigenic determinants in common with the two FeLV amino terminal gag gene proteins, p15 and p12 (18, 23) , and also crossreacts with the tumor-specific feline oncornavirusassociated cell membrane antigen (FOCMA) (18, 23 (Fig. 1) . The possibility (17), and individual column fractions were tested in a heterologous competition immunoassay using antibody to R-MuLV for precipitation of 125I-labeled M-MuLV p12 as described for Fig. 1 .
that the high-Mr p15, p12 antigenic reactivity might represent an aggregate was ruled out by the fact that a similar peak of reactivity was observed when the clone 64Ab2 extract was subjected to gel filtration in the presence of 6 M guanidine.HCl ( Fig. 2A) . Analysis of two additional AbLV-transformed mink cell clones yielded similar 110,000-to 130,000-Mr peaks of antigenic reactivity (data not shown). In contrast, when subjected to similar analysis under either nondenaturing (data not shown) or denaturing (Fig. 2B) conditions, ANN-1 cells were found to express the 110,000-to 130,000-Mr polyprotein at much lower concentration. Proportionately higher peaks of p12 antigenic reactivity were observed at molecular weights of 25,000 and 12,000 (Fig. 2B) . While a low level of antigenic reactivity corresponding to MuLV p15 was located at 110,000-130,000 Mr, most such reactivity chromatographed as peaks at molecular weights of 25,000 and 15,000 (data not shown).
As an independent test of the specificity of the MuLV gag gene-coded immunologic reactivities in the ANN-1 and 64Ab2 clones, extracts of each were tested in a series of highly typespecific p12 immunoassays. As shown in Fig. 3 , cell extracts prepared from both the ANN-1 and 64Ab2 clones competed equally as well (>90%) as density-gradient-purified M-MuLV in a homologous immunoassay for M-MuLV p12. In contrast, each of a number of other prototype mouse type C viruses tested, including AKR-MuLV, BALB:virus-2, R-MuLV, and NIH-MuLV, competed to final extents of only around 50%. Moreover, neither the ANN-1 nor the 64Ab2 extracts competed to more than 50% in homologous competition immunoassays for AKR-MuLV, BALB:virus-2, R-MuLV, or NIH-MuLV p12 (data not shown). These findings are consistent with the fact that the helper virus in the stock from which AbLV was originally derived was M-MuLV (16) 
competing antigens included AKR-MuLV (-), NIH-MuLV (a), BALB:virus-2 (a), R-MuLV (*), and M-MuLV (0). Cell extracts included: ANN-1 (Q), NIH/3T3 (A), 64Ab2 (-), CCL64 (@), and 64 M1 (A).
subjected to preparative isoelectric focusing, and individual fractions were analyzed by competition immunoassay for both .M-MuLV p15 and p12 reactivity. For comparison, densitygradient-purified M-MuLV was subjected to similar analysis. As shown in Fig. 4 Isoelectric focusing analysis of the 110,000-to 130,000-Mr precursors partially purified from the AbLV-transformed mink nonproducer cell clone 64Ab2. Antigen-positive fractions from the 100,000-to 130,000-M, region of the AcA 34 gel filtration column described for Fig. 1 were pooled, dialyzed at 40 against 0.01 M TrisHCl (pH 7.8), lyophilized, resuspended in 1 ml of water, and subjected to isoelectric focusing (32) . Two-milliliter fractions were collected and analyzed by competition immunoassay utilizing antibody to M-MuLV for precipitation of 125I-labeled M-MuLV p12. Results are expressed as the percentage of total antigenic reactivity in each column fraction as described for Fig. 1 . The isoelectric points for M-MuLV p12 and p15 and for the p15-p12 precursor, indicated by vertical arrows, were determined on separate columns. ditional less pronounced peaks of reactivity were observed at 25,000 and 12,000 Mr. Both the 110,000-to 130,000-Mr and 25,000-Mr peaks were also found to contain antigenic reactivity for M-MuLV p15 (data not shown). In contrast, similar analysis of AbLV(4070-A) pseudotype virus released a major peak of M-MuLV p12 at around 70,000 Mr with additional peaks of reactivity at 25,000 and 12,000 Mr. Interestingly, column fractions containing M-MuLV p12 reactivity at 70,000 Mr were not detectably reactive in the M-MuLV p15 assay (data not shown). These 
DISCUSSION
AbLV is a replication-defective transforming virus, derived by in vivo passage of M-MuLV in mice (7) , and appears to represent a genetic recombinant between M-MuLV and host cellular sequences responsible for malignant transformation (35) . Upon inoculation in vivo, AbLV induces B-cell lymphoid leukemia, while in vitro the virus has been shown to transform both lymphoid cells (36) and embryo fibroblasts (24 spectively. The virus-coded nature of the entire 110,000-to 130,000-Mr polyprotein is established by its efficient translation in Xenopus Iaevis oocytes using AbLV-genomic RNA as message (37) .
Awaiting resolution is the question of whether the nonstructural component of the AbLV-coded polyprotein is located at its amino or the carboxy terminus. If it occupies a carboxyterminal position, as would be predicted by the above model, the 110,000-to 130,000-Mr precursor probably contains a small portion of p30 and thus the p12-p3O cleavage site (38) . This would account for the post-translational processing of the 110,000-to 130,000-Mr precursor and is consistent with the lack of detectable p30 or plO in the AbLV nonproducer cells, because the expression of a small portion of the p30 molecule would not be detected by the immunologic assays used in the present study.
Several identities are possible for the nonstructural component of the high-Mr polyprotein expressed in AbLV-transformed cells. Although the present findings argue against the possibility that it is an immunologically reactive translation product of either env or pol genes, the possibility that it contains immunologically nonreactive sequences coded for by either pol or env cannot be excluded. Alternatively, it might represent a nonsense protein produced as a result of a small deletion causing a frame shift in translation of a portion of the gag and poi genes. This possibility, however, seems unlikely in view of the high probability of encountering a termination codon prior to completion of translation. Finally, the nonstructural component of the AbLV-coded polyprotein could represent the translational product of the AbLV src gene or the product of another cellular gene also linked to the viral structural genetic information by a recombination event. The weight of indirect 3978 Medical Sciences: Reynolds et al. evidence would seem to favor its identity as a src gene product, on the basis of analogy to findings recently obtained in studies of other RNA tumor viruses. For instance, in the feline system, a 110,000-to 130,000-Mr translational product of the FeSV genome containing FeLV p15 and p12 linked to a 60,000-Mr nonstructural component has been shown to react with tumor-specific antisera (2, 33, 34 ). An avian RNA tumor virus-(MC29) coded polyprotein consisting of two avian leukemia virus gag gene proteins, p19 and p27, linked to a 60,000-Mr nonstructural protein has also been described (39) . By oligonucleotide map analysis, the region of the viral genome coding for this latter protein has been shown to be absent from the leukemia virus genome from which MC29 was derived (40) .
In view of both the present findings and our previous results with the FeSV genome (18, 23) , the extent of post-translational processing of sarcoma virus-coded p15-p12-containing precursors appears influenced by the species of origin of the nonproductively transformed cell and by the helper virus used in the production of pseudotypes. For instance, while neither the AbLV-coded (present findings) nor the FeSV-coded (23) polyprotein precursors are cleaved to more than limited extents in mink nonproducer lines, they undergo extensive cleavage as nonproductive transformants of mouse or rat cells, respectively. Moreover 
